January presentation is impressive to me:
https://s201.q4cdn.com/710325604/files/ ... 1-7-24.pdf
Search found 353 matches
- Mon Feb 05, 2024 9:37 pm
- Forum: ImetelChat
- Topic: January Presentation
- Replies: 4
- Views: 1604
- Sat Feb 03, 2024 7:46 pm
- Forum: ImetelChat
- Topic: ADCOM
- Replies: 96
- Views: 295022
Re: ADCOM
Go play some Tom Petty. “The waaaaaaaa—aaaitin is the hardest part.”
- Wed Jan 31, 2024 9:21 pm
- Forum: ImetelChat
- Topic: less competition
- Replies: 5
- Views: 1999
Re: less competition
My take on your question about Dr. Steensma's intent, which of course is an uneducated guess: I think High Risk and Low Risk MDS are just different diseases. You know that, and I think in that is the reason. This expert is focusing on the High Risk designation, and is not considering imet yet withou...
- Wed Jan 31, 2024 4:48 pm
- Forum: ImetelChat
- Topic: less competition
- Replies: 5
- Views: 1999
Re: less competition
Click the link to see the reaction from Dr. Steensma. (Don’t need to login to see…) https://twitter.com/DavidSteensma/status/1752682957171474463 “Discouraging news today: #MDSsm sabatolimab+azacitidine STIMULUS-MDS2 trial was negative (no OS benefit vs aza alone.) It has been so long since there was...
- Tue Jan 30, 2024 4:13 pm
- Forum: ImetelChat
- Topic: Official 8k notice of ODAC advisory meeting
- Replies: 4
- Views: 1577
Re: Official 8k notice of ODAC advisory meeting
At least it’s on that Thursday and not Friday…
Beware of the Ides of March.
Onwards…
Beware of the Ides of March.
Onwards…
- Wed Jan 24, 2024 8:42 pm
- Forum: ImetelChat
- Topic: FDA Boxed Warning for CAR-T
- Replies: 2
- Views: 1480
Re: FDA Boxed Warning for CAR-T
6 Papers from Dana-Farber Cancer Institute retracted. Altered images fooled peer reviewers, just shocking. Correction: I can’t confirm that these retracted papers were CAR-T Seems as if fabricating medical research has become an epidemic: https://www.science.org/content/article/whistleblowers-flagge...
- Sat Jan 20, 2024 2:46 am
- Forum: ImetelChat
- Topic: ADCOM
- Replies: 96
- Views: 295022
Re: ADCOM
Definitely some interesting points here.
It’s only a matter of time at this point… 5 months maximum at this point. Unbearable but still a finite amount that we can count on one hand.
It’s only a matter of time at this point… 5 months maximum at this point. Unbearable but still a finite amount that we can count on one hand.
- Mon Jan 15, 2024 11:53 pm
- Forum: ImetelChat
- Topic: A new Irish Trader? Hat tip to Paul C
- Replies: 17
- Views: 7198
Re: A new Irish Trader? Hat tip to Paul C
There is little doubt that this is a true testimonial from a real patient… given the details supplied about treatments before Imetelstat in particular. And I wouldn’t see this as surprising either, the data we have all seen has shown this type of improvement. It is great to see a real story and live...
- Tue Jan 09, 2024 5:15 pm
- Forum: ImetelChat
- Topic: ICER - Institute for Clinical and Economic Review
- Replies: 5
- Views: 1324
Re: ICER - Institute for Clinical and Economic Review
I wonder if the FDA pays attention to the ICER findings. I wouldn’t know but I wouldn’t think so. I believe such an independent panel could influence Insurance companies and regulators for the points BP referenced. It is interesting that there is an open call for input into late January. I’d be int...
- Tue Jan 09, 2024 3:09 pm
- Forum: ImetelChat
- Topic: ICER - Institute for Clinical and Economic Review
- Replies: 5
- Views: 1324
Re: ICER - Institute for Clinical and Economic Review
From their website: “ICER provides an independent source of evidence review—free from financial conflicts of interest—to address these fundamental questions. By doing so, we help patients today and in the future by catalyzing a movement toward fair pricing, fair access, and future innovation across ...
- Tue Jan 09, 2024 6:38 am
- Forum: ImetelChat
- Topic: ICER - Institute for Clinical and Economic Review
- Replies: 5
- Views: 1324
ICER - Institute for Clinical and Economic Review
ICER to Evaluate Geron’s Imetelsta for the Treatment of MDS https://www.navlindaily.com/article/20031/icer-to-evaluate-geron-s-imetelsta-for-the-treatment-of-mds Imetelstat for Anemia in Myelodysplastic Syndrome Draft Background and Scope January 3, 2024 https://icer.org/wp-content/uploads/2024/01/M...
- Sun Jan 07, 2024 8:27 pm
- Forum: ImetelChat
- Topic: Off-Topic - GERN stock
- Replies: 4
- Views: 1643
Re: Off-Topic - GERN stock
Geron has recently added a Sr. Director/Legal Counsel who started her career with the FDA. Perhaps this helps with the MA lock? -Kmall Nice piece of info and I align with the call. However, I have little doubt that while we wait for marketing authorization, and perhaps even as Revenue begins, our ‘...
- Fri Jan 05, 2024 11:50 pm
- Forum: ImetelChat
- Topic: Off-Topic - GERN stock
- Replies: 4
- Views: 1643
Off-Topic - GERN stock
For Imetelstat, I think we are in a great place. 5 month countdown is on (if that) and the chance of marketing authorization does seem a lock. The data though.
For GERN stock, given Week #1, expect max pain this year, IMO.
For GERN stock, given Week #1, expect max pain this year, IMO.
- Fri Dec 29, 2023 6:34 pm
- Forum: ImetelChat
- Topic: A few thoughts for the end of the old year and the beginning of the new
- Replies: 5
- Views: 2285
Re: A few thoughts for the end of the old year and the beginning of the new
All good thoughts. My guess is the vast majority of individuals on this board are gassed, but the announcements in Q1 and definitely Q2 should catalyze a reinvigorated group. I still think the standard review, really the only “bad” news of the year for the drug, is to review what is a new class of d...
- Fri Dec 22, 2023 4:16 am
- Forum: ImetelChat
- Topic: ASCO Post
- Replies: 0
- Views: 1490
- Thu Dec 21, 2023 10:58 pm
- Forum: ImetelChat
- Topic: 2023 - What a Long, Strange Trip it’s Been
- Replies: 3
- Views: 2842
Re: 2023 - What a Long, Strange Trip it’s Been
And no announcement for Imet 2.0 ( I would suspect that is coming in the first half of January)…
But of course one more round of Inducement Grants to end up the year! Can’t believe I didn’t reference Inducements as another main theme for the year.
Build that team, I’m not mad at ya.
But of course one more round of Inducement Grants to end up the year! Can’t believe I didn’t reference Inducements as another main theme for the year.
Build that team, I’m not mad at ya.
- Wed Dec 20, 2023 6:28 pm
- Forum: ImetelChat
- Topic: 2023 - What a Long, Strange Trip it’s Been
- Replies: 3
- Views: 2842
2023 - What a Long, Strange Trip it’s Been
As I look at the stock price, and realize that for the year the pps is going to be just about where it was on December 31, 2022, I realize what a crazy year it’s been for Geron. (Hence the Grateful Dead lyric.) Remember that it was in the first week of January that the MDS Phase III initial results ...
- Fri Dec 15, 2023 8:58 pm
- Forum: ImetelChat
- Topic: About two weeks
- Replies: 4
- Views: 9268
Re: About two weeks
Another video, posted on Yahoo! this morning:
https://m.youtube.com/watch?si=EYbTtt-Q ... e=youtu.be
https://m.youtube.com/watch?si=EYbTtt-Q ... e=youtu.be
- Tue Dec 12, 2023 5:48 am
- Forum: ImetelChat
- Topic: Geron Announces IMerge Phase 3 Presentations at ASH Highlighting Significant Durability of Transfusion Independence and
- Replies: 1
- Views: 2697
Geron Announces IMerge Phase 3 Presentations at ASH Highlighting Significant Durability of Transfusion Independence and
https://ir.geron.com/investors/press-releases/press-release-details/2023/Geron-Announces-IMerge-Phase-3-Presentations-at-ASH-Highlighting-Significant-Durability-of-Transfusion-Independence-and-Breadth-of-Effect-Across-MDS-Subgroups-with-Imetelstat-in-Lower-Risk-MDS/default.aspx “As we continue to se...
- Tue Dec 12, 2023 2:34 am
- Forum: ImetelChat
- Topic: Adverse effects
- Replies: 8
- Views: 11386
Re: Adverse effects
Plenary session during the ASH conference. Has no relevance to FDA decision on marketing authorization.